Skip to main navigation Skip to search Skip to main content

Gait analysis in patients with advanced Parkinson disease: Different or additive effects on gait induced by levodopa and chronic STN stimulation

  • S. Lubik*
  • , W. Fogel
  • , V. Tronnier
  • , M. Krause
  • , J. König
  • , W. H. Jost
  • *Corresponding author for this work
  • Augenklinik der Stadtischen Kliniken
  • German Clinic of Diagnostics
  • Ruprecht-Karls Universität Heidelberg
  • Saarland University

Abstract

The aim of our study was to observe the effects on gait parameters induced by STN stimulation and levodopa medication in patients with advanced Parkinson's disease in order to determine different or additive effects. Therefore we examined 12 patients with advanced Parkinson disease after bilateral implantation of DBS into the STN. We assessed the motor score of the UPDRS and quantitative gait analysis under 4 treatment conditions: with and without stimulation as well as with and without levodopa. The mean improvement of the UPDRS motor score was almost the same with levodopa and DBS. Combining both therapies we saw a further improvement of the motor score. Gait parameters of patients with PD treated either with levodopa or STN stimulation were greatly improved. A significant difference between levodopa and STN stimulation could only be shown for the parameters velocity and step length. These parameters improved more with levodopa than with stimulation. The combination of both therapeutic methods showed the best results on the UPDRS motor score and gait parameters.

Original languageEnglish
JournalJournal of Neural Transmission
Volume113
Issue number2
Pages (from-to)163-173
Number of pages11
ISSN0300-9564
DOIs
Publication statusPublished - 02.2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this